Literature DB >> 18585133

Voltammetric reduction of finasteride at mercury electrode and its determination in tablets.

A Alvarez-Lueje1, S Brain-Isasi, L J Núñez-Vergara, J A Squella.   

Abstract

Finasteride in hydroalcoholic solutions (ethanol/Britton-Robinson buffer, 30/70) exhibits cathodic response in a wide range of pH (-0.5 to 12) using differential pulse (DPP) and test polarography (TP). The reduction peak of finasteride at acidic pH, is a catalytic proton peak resulting from a mechanism involving a first protonation of finasteride followed by the reduction of the protons combined with finasteride in order to regenerate finasteride and liberate hydrogen. Based on the catalytic hydrogen wave, a novel method for the determination of finasteride can be proposed. For analytical purposes we selected DPP technique in an ethanol/0.0625 mol L(-1) H(2)SO(4) (30/70) solution medium. In this condition the I(p) varied linearly with finasteride concentration between 5 x 10(-5) and 5 x 10(-4) mol L(-1). Within-day and inter-day reproducibility's were adequate with R.S.D. values lower than 2%. The selectivity of the method was checked with both accelerated degradation trials and typical excipients formulations. The developed method was applied to the assay and the uniformity content of finasteride tablets and compared with the standard HPLC method. The DPP-developed method was adequate for the finasteride determination in pharmaceutical forms as that exhibited an adequate accuracy, reproducibility and selectivity. Furthermore, treatment of the sample was not required as in HPLC; the method is not time-consuming and less expensive than the HPLC ones.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18585133     DOI: 10.1016/j.talanta.2007.12.004

Source DB:  PubMed          Journal:  Talanta        ISSN: 0039-9140            Impact factor:   6.057


  3 in total

1.  Electrochemical determination of closantel in the commercial formulation by square-wave adsorptive stripping voltammetry.

Authors:  Mariola Brycht; Agnieszka Nosal-Wiercińska; Karolina Sipa; Konrad Rudnicki; Sławomira Skrzypek
Journal:  Monatsh Chem       Date:  2016-10-28       Impact factor: 1.451

2.  Simultaneous spectrophotometric determination of finasteride and tadalafil in recently FDA approved Entadfi™ capsules.

Authors:  Ahmed H Abdelazim; Sherif Ramzy
Journal:  BMC Chem       Date:  2022-07-29

3.  Optimization and validation of spectrophotometric methods for determination of finasteride in dosage and biological forms.

Authors:  Alaa S Amin; Mohammed A Kassem
Journal:  Pharm Methods       Date:  2012-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.